Other Clinical Trial - A Study of Concurrent Chemoradiotherapy Based of

See also
Status	Clinical Trial	Phase
Completed	`NCT03650699` - Biofeedback Rehabilitation to Improve Speaking and Eating in Public	N/A
Recruiting	`NCT05098119` - Neoadjuvant Sintilimab Combined With Reduction of Cycles of Chemotherapy in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma (OOC-002)	Phase 2
Terminated	`NCT03053960` - Helical CT, PET/CT, MRI, and CBCT Alone or in Combination in Predicting Jaw Invasion in Patients With Oral Cancer
Recruiting	`NCT05876247` - Articulatory Adaptation Following Oral Cancer Treatment
Completed	`NCT03618654` - Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma	Early Phase 1
Recruiting	`NCT04801472` - Optimisation of Potential Dental Implant Sites Protection for Rehabilitation in Patients With Head and Neck Cancer: Impact of Virtual Implants Visualisation on Dosimetry (OPPIDOM)	N/A
Recruiting	`NCT05316688` - A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery	Phase 1/Phase 2
Recruiting	`NCT04858269` - First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients	Phase 2
Active, not recruiting	`NCT03529604` - Salivary Ap4A, SCCA, TROP2 in Oral Cancer Patients
Completed	`NCT03028766` - WEE1 Inhibitor With Cisplatin and Radiotherapy: A Trial in Head and Neck Cancer	Phase 1
Recruiting	`NCT05681039` - Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).	Phase 2
Completed	`NCT03510390` - Metformin in Head and Neck Squamous Cell Carcinoma: Effect on Tissue Oxygenation	N/A
Recruiting	`NCT05578170` - Efficacy and Safety of Neoadjuvant Pembrolizumab in III-IVA Resectable Oral Squamous Cell Carcinoma
Recruiting	`NCT05950737` - Sentinel Node Biopsy in Early Oral Cancers a Tertiary Cancer Centre Experience	N/A
Recruiting	`NCT04333537` - Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer	Phase 2/Phase 3
Recruiting	`NCT03727594` - Radioguided Selective Neck Dissection for Staging and Treatment of Oral Cavity and Oropharyngeal Squamous Cell Carcinoma
Terminated	`NCT02582008` - Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy	Early Phase 1
Recruiting	`NCT06097468` - Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)	Phase 1/Phase 2
Withdrawn	`NCT04892875` - A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers	Phase 1
Active, not recruiting	`NCT03784066` - Durvalumab With or Without Tremelimumab in Resectable Locally Advanced Squamous Cell Carcinoma of the Oral Cavity	Phase 1/Phase 2

NCT number	NCT05749042
Study type	Interventional
Source	China Three Gorges University, Yichang, China
Contact	Xinhua Xu, Master
Phone	+8613986747496
Email	2732774352@qq.com
Status	Recruiting
Phase	Phase 2
Start date	January 18, 2023
Completion date	January 18, 2025

A Study of Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms